Logo image of ALSAF.PA

SAFE ORTHOPAEDICS SA (ALSAF.PA) Stock Fundamental Analysis

Europe - EPA:ALSAF - FR001400ZU25 - Common Stock

0.0024 EUR
0 (0%)
Last: 6/30/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, ALSAF scores 2 out of 10 in our fundamental rating. ALSAF was compared to 62 industry peers in the Health Care Equipment & Supplies industry. ALSAF has a bad profitability rating. Also its financial health evaluation is rather negative. ALSAF is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALSAF has reported negative net income.
ALSAF had negative earnings in each of the past 5 years.
ALSAF had a negative operating cash flow in each of the past 5 years.
ALSAF.PA Yearly Net Income VS EBIT VS OCF VS FCFALSAF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of ALSAF (-342.67%) is worse than 92.98% of its industry peers.
Industry RankSector Rank
ROA -342.67%
ROE N/A
ROIC N/A
ROA(3y)-117.06%
ROA(5y)-110.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSAF.PA Yearly ROA, ROE, ROICALSAF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

1.3 Margins

ALSAF has a better Gross Margin (74.41%) than 84.21% of its industry peers.
ALSAF's Gross Margin has improved in the last couple of years.
ALSAF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.84%
GM growth 5Y11.39%
ALSAF.PA Yearly Profit, Operating, Gross MarginsALSAF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

More info and screens

0

2. Health

2.1 Basic Checks

ALSAF does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALSAF has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALSAF has been increased compared to 5 years ago.
Compared to 1 year ago, ALSAF has a worse debt to assets ratio.
ALSAF.PA Yearly Shares OutstandingALSAF.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20K 40K 60K 80K 100K
ALSAF.PA Yearly Total Debt VS Total AssetsALSAF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -13.66, we must say that ALSAF is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -13.66, ALSAF is not doing good in the industry: 89.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.66
ROIC/WACCN/A
WACC3.69%
ALSAF.PA Yearly LT Debt VS Equity VS FCFALSAF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M -150M -200M

2.3 Liquidity

A Current Ratio of 0.04 indicates that ALSAF may have some problems paying its short term obligations.
ALSAF's Current ratio of 0.04 is on the low side compared to the rest of the industry. ALSAF is outperformed by 94.74% of its industry peers.
ALSAF has a Quick Ratio of 0.04. This is a bad value and indicates that ALSAF is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.02, ALSAF is not doing good in the industry: 94.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.02
ALSAF.PA Yearly Current Assets VS Current LiabilitesALSAF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALSAF have decreased by -2.53% in the last year.
The Revenue has decreased by -0.87% in the past year.
The Revenue has been growing by 10.85% on average over the past years. This is quite good.
EPS 1Y (TTM)-2.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.87%
Revenue growth 3Y16.67%
Revenue growth 5Y10.85%
Sales Q2Q%N/A

3.2 Future

ALSAF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.47% yearly.
Based on estimates for the next years, ALSAF will show a quite strong growth in Revenue. The Revenue will grow by 15.92% on average per year.
EPS Next Y41.67%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.31%
Revenue Next 2Y15.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALSAF.PA Yearly Revenue VS EstimatesALSAF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
ALSAF.PA Yearly EPS VS EstimatesALSAF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100M -200M -300M -400M -500M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALSAF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALSAF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSAF.PA Price Earnings VS Forward Price EarningsALSAF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSAF.PA Per share dataALSAF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10K -20K -30K -40K -50K

4.3 Compensation for Growth

A more expensive valuation may be justified as ALSAF's earnings are expected to grow with 22.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALSAF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFE ORTHOPAEDICS SA

EPA:ALSAF (6/30/2025, 7:00:00 PM)

0.0024

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)06-30 2025-06-30
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap431.99999999999994
Revenue(TTM)5.81M
Net Income(TTM)-205444000
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-54931.55
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.28
BVpS-834.97
TBVpS-835
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -342.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.41%
FCFM N/A
ROA(3y)-117.06%
ROA(5y)-110.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.84%
GM growth 5Y11.39%
F-ScoreN/A
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.02
Altman-Z -13.66
F-ScoreN/A
WACC3.69%
ROIC/WACCN/A
Cap/Depr(3y)105.32%
Cap/Depr(5y)103.66%
Cap/Sales(3y)19.53%
Cap/Sales(5y)16.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y41.67%
EPS Next 2Y22.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.87%
Revenue growth 3Y16.67%
Revenue growth 5Y10.85%
Sales Q2Q%N/A
Revenue Next Year20.31%
Revenue Next 2Y15.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y79.23%
OCF growth 3YN/A
OCF growth 5YN/A

SAFE ORTHOPAEDICS SA / ALSAF.PA FAQ

What is the fundamental rating for ALSAF stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALSAF.PA.


What is the valuation status of SAFE ORTHOPAEDICS SA (ALSAF.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to SAFE ORTHOPAEDICS SA (ALSAF.PA). This can be considered as Overvalued.


Can you provide the profitability details for SAFE ORTHOPAEDICS SA?

SAFE ORTHOPAEDICS SA (ALSAF.PA) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ALSAF stock?

The Earnings per Share (EPS) of SAFE ORTHOPAEDICS SA (ALSAF.PA) is expected to grow by 41.67% in the next year.